About Abiomed
Abiomed is a Healthcare company based in Danvers (United States) founded in 1981, and was acquired by Johnson & Johnson in November 2022. Heart pumps are developed for blood circulation and oxygenation support. The company has 1,157 employees. Abiomed has completed 3 acquisitions, including Breethe, Impella and preCARDIA. Its website abiomed.com draws about 35 thousand monthly visits. Abiomed offers products and services including Impella Heart Pumps and Impella Connect Services. Its focus areas include Traditional Medical Devices.
Company details
Abiomed was founded in 1981 and is based in Danvers, United States, within the medical device sector focused on cardiovascular technologies. Operations center on devices that assist heart function, including the Impella heart pump designed for hemodynamic support during procedures. The OXY-1 System is also provided as a portable cardiopulmonary unit with built-in oxygen supply to enable patient mobility. These offerings address needs in cardiac care and circulation management.
- Headquarters Danvers, United States
- Employees 1,157
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website abiomed.com/en-us
- Social LinkedIn X
- Acquired by Johnson & Johnson (Nov 2022)
- Legal Name Abiomed
- Annual Revenue$1.03 B (USD)22as on Mar 31, 2022
- Net Profit$136.51 M (USD)-39as on Mar 31, 2022
- EBITDA$140.72 M (USD)-39as on Mar 31, 2022
- Latest Funding Round$99.67K (USD), Grant
Aug 2010
- InvestorsJohnson & Johnson
& 2 more
- Employee Count1,157
- Investments & AcquisitionsBreethe
& 2 more
- Acquired byJohnson & Johnson
(Nov 2022)
Products & Services of Abiomed
Abiomed offers a comprehensive portfolio of products and services, including Impella Heart Pumps and Impella Connect Services.
Impella heart pumps are employed to deliver temporary circulatory support for patients with heart conditions, facilitating procedures like protected PCI.
Support services are offered to provide clinical assistance and resources that aid health care professionals in managing patient care effectively.
Funding Insights of Abiomed
- Total Rounds 8
- Last Round Grant — $99,665
- First Round $20.12M
(Jun 2005)
- Investors Count 2
All 8 funding rounds of Abiomed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
3 investors in total: 3 institutional.
Investors in Abiomed
Abiomed has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Johnson & Johnson, HHS and EW Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | ewhealthcare.com | New York, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | jnj.com | New Brunswick, United States |
Investor details for Abiomed
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Abiomed
296 people are tracked at Abiomed (52 in leadership, 244 in team); the tracked headcount is 1,157.
| Name | Role | Group |
|---|---|---|
Edward Tacvorian | Associate Director, Connected Product Technologies, Platform Risk & Security | Leadership |
Annie Ferreri | Director Quality Integration | Leadership |
Chris Korkuch | Associate Director ECP Platform | Leadership |
Buzzy Spain | Director, Cloud Product Engineering | Leadership |
Xiaole Hong | Chief System Engineer | Leadership |
Steven Balk | Director, Virtual Proctoring | Leadership |
Charles Perkins | Associate Director Product Development | Leadership |
Geri Hansen | Physician Program Director | Leadership |
Amy Raque | Vice President, Americas | Leadership |
Brad Sparlin | Surgical Director - Mountain | Leadership |
Michael Itkoff | Director, Key Accounts And Physician Programs | Leadership |
Andres Lopez | Senior Director - Global Deliver | Leadership |
Max Fowler | Associate Director - Physician Programs Uk&i | Leadership |
Sonya Bhavsar | Senior Director Of Product Development | Leadership |
Lauren Remare | Executive Assistant, Office Of The President | Leadership |
Jay Hoynacki | Area Vice President - Pacific Coast | Leadership |
Kathy Hall | Physician Program Director | Leadership |
Kenneth Spinale | Director, US Plant Quality | Leadership |
Kameel Maharaj | Director: Medical Safety | Leadership |
Ali Almedhychy | Medical Director | Leadership |
276 more people are available in the full profile.
Complete people profiles for Abiomed
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Abiomed
Abiomed has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Breethe, Impella and preCARDIA.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
A device for treating acute decompensated heart failure is developed. | precardia.com | Saint Paul, United States | 2016 | Jun 2021 | •••• | |
Meditation programs are delivered through a mobile app by Breethe. | breethe.com | Montreal, Canada | 2014 | Jul 2020 | •••• | |
Ventricular assist devices are provided for cardiac hemodynamic support. | impella.com | Aachen, Germany | 1998 | Apr 2005 | $1.8M |
Complete acquisition details for Abiomed
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Abiomed
8 dated milestones of Abiomed across 41 years, from founding to its latest funding, stage changes and deals.
- Founded Abiomed is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Impella.
- Funding First funding round of $20.1M.
- Funding Latest funding round, Grant, of $100K.
- Acquisition Acquires Breethe.
- Acquisition Acquires preCARDIA.
- Exit Acquired by Johnson & Johnson.
Web traffic of Abiomed
The website of Abiomed (abiomed.com) receives about 34.6K visits a month.
- Monthly visits34.6K
▼ 29.5% vs previous month
Websites whose visitors overlap most with Abiomed. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| thoratec.com | 100% | View details | |||
| heartware.com | 91% | View details | |||
| affinitymed.com | 88% | View details | |||
news.sphp.com | news.sphp.com | 87% | #1,180,173 | – | |
| dicardiology.com | 83% | 79.8K | #510,652 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Abiomed
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Traditional Diagnostics & Medical Devices
3 companies that operate in the same segment as Abiomed (Traditional Diagnostics & Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 19.48 B | 95,424 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | ||||
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Abiomed
Abiomed was founded in 1981 and raised its 1st funding round 24 years after it was founded.
Abiomed is headquartered in Danvers, United States. It is registered at Danvers, Massachusetts, United States.
Abiomed has 1,157 employees.
Annual revenue of Abiomed is $1.03B as on Mar 31, 2022.
Abiomed was founded in 1981 and is based in Danvers, United States, within the medical device sector focused on cardiovascular technologies. Operations center on devices that assist heart function, including the Impella heart pump designed for hemodynamic support during procedures. The OXY-1 System is also provided as a portable cardiopulmonary unit with built-in oxygen supply to enable patient mobility. These offerings address needs in cardiac care and circulation management.
Abiomed offers Impella Heart Pumps and Impella Connect Services.
Abiomed has 3 investors. Key investors include Johnson & Johnson, HHS, and EW Healthcare Partners.
Abiomed operates through Abiomed.
Yes. Abiomed was acquired by Johnson & Johnson in November 2022.